Given that SMC dysfunction and elastin degradation are central to the progression of both aortic and intracranial aneurysms, hyaluronic acid nanoparticles could be adapted to stimulate elastin production in cerebral arteries, potentially slowing aneurysm growth. The gene discussed is ELN; the disease is Dilatation of the cerebral artery.